LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Entrada Therapeutics (NASDAQ: TRDA)

Follow NASDAQ:TRDA Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ TRDA Entrada Therapeutics
WENTWORTH KORY JAMES / officer: Chief Financial Officer
03/17/2025
Sell
$10.67
1,784
$19K
109,536
NASDAQ TRDA Entrada Therapeutics
Doshi Dipal / director, officer: CEO
03/03/2025
Sell
$11.68
17,566
$205K
424,387
NASDAQ TRDA Entrada Therapeutics
Doshi Dipal / director, officer: CEO
03/01/2025
Buy
$11.94
173,400
$2.070M
173,400
NASDAQ TRDA Entrada Therapeutics
WENTWORTH KORY JAMES / officer: Chief Financial Officer
03/03/2025
Sell
$11.68
4,929
$58K
111,320
NASDAQ TRDA Entrada Therapeutics
WENTWORTH KORY JAMES / officer: Chief Financial Officer
03/01/2025
Buy
$11.94
63,300
$756K
63,300
NASDAQ TRDA Entrada Therapeutics
Dowden Nathan J / officer: President & COO
03/03/2025
Sell
$11.68
5,144
$60K
180,805
NASDAQ TRDA Entrada Therapeutics
Dowden Nathan J / officer: President & COO
03/01/2025
Buy
$11.94
90,800
$1.084M
90,800
NASDAQ TRDA Entrada Therapeutics
Sethuraman Natarajan / officer: President, Research & Develop.
03/03/2025
Sell
$11.68
6,138
$72K
199,659
NASDAQ TRDA Entrada Therapeutics
Sethuraman Natarajan / officer: President, Research & Develop.
03/01/2025
Buy
$11.94
90,800
$1.084M
90,800

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous